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Abstract
In Wolff-Parkinson-White Syndrome (WPW), presence of accessory pathways causes various 
tachyarrhythmias that lead to different symptoms and clinical conditions in patients. Atrial 
fibrillation is observed in about 20-30% of this group of patients. Life threatening malignant 
ventricular arrhythmias and sudden cardiac deaths are observed in patients having rapid 
conduction in accessory pathways and short antegrade refractory periods (<250 msn). We 
present a WPW syndrome case that presented to the emergency service with narrow QRS 
tachycardia and later developed malignant ventricular arrhythmia.                           
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Case   Report                                                                              
A 32 years old male with no previous cardiac evaluation and clinical complaints presented to the 
emergency service with palpitation. Due to narrow QRS complex tachycardia, emergency 
service physicians (Figure 1) administered intravenous verapamil for rate control. Meanwhile, 
the patient developed atrial fibrillation with wide QRS and high ventricular response (Figure 2) 
and then ventricular fibrillation. Normal sinus rhythm was achieved after multiple defibrillations 
(220 joule, Biphasic). Hemodynamic parameters and respiration were stabilized. 12 lead ECG 
showed characterstic delta waves and short PR interval. (Figure 3). Given these findings, the 
case was diagnosed as Wolff-Parkinson-White (WPW) syndrome. His physical examination, 
biochemical parameters and echocardiography were normal. As the case was a WPW syndrome 
case and as malignant ventricular arrhythmia and cardiopulmonary arrest developed due to atrial 
fibrillation, he was assigned to electrophysiological (EPS) study. In our case, whose orthodromic 
tachycardia was induced again during EPS (Figure 4). An accessory pathway was found at left 
anterior localization based on intracardiac findings, and successful ablation was achieved in the 
same session (Figure 5). On the surface ECG, it was observed that PR interval was back to 
normal and delta wave was no more present. The case was asymptomatic and his ECG was 
normal during his controls at 1st and 6th months.
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Figure 1: Narrow QRS complex tachycardia at presentation
Figure 2: Atrial fibrillation with wide QRS and high ventricular response
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Figure 3: 12 lead ECG showing characterstic delta waves and short PR interval of WPW 
syndrome
Figure 4: Orthodromic tachycardia induced during EPS
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Figure 5
Discussion
WPW syndrome is a clinical entity characterized by presence of an electrical signaling accessory 
pathway between atrium and ventricular that may cause tachyarrhythmia's sometimes and sudden 
cardiac death. Studies have shown that SCD occurs at the rate of 0.15% per year in patients with 
WPW. These deaths are caused by atrial fibrillation with rapid ventricular response that leads to 
ventricular fibrillation (VF) [1,2].                                                                  
The most frequently encountered tachycardia in WPW syndrome is the reentrant tachycardia. The 
degeneration of reciprocating tachycardia to atrial fibrillation is not uncommon [3]. It has been 
estimated that atrial fibrillation (AF) is observed in approximately one third of WPW patients. AF 
may cause fatal arrhythmias in WPW syndrome [4]. Sudden death occurs due to transmission of 
AF into VF with a rapid ventricular response over one or more accessory pathways with a short 
antegrade refractory period [5]. The first presentation of some WPW patients with asymptomatic 
clinical course could be due to ventricular fibrillation [6].                                         
Risks factors for sudden death in WPW are presence of more than one AP, development of AVRT 
along with AF and the shortest preexcitation RR interval less than 260 msn [1,2,7]. Development 
of atrial fibrillation as a result of   IV verapamil administration for rate control in reciprocal 
tachycardia is not rare [8]. Straberg et al reported 3 cases presented with  atrial fibrillation and 
rapid ventricular response with wide preexcitation QRS, all of whom received intravenous 
verapamil (5-10 mg); and they stated that one of the patients developed ventricular fibrillation 
requiring several defibrillations, the other had hemodynamic deterioration and the last one had a  
marked  increment  in the ventricular response. When verapamil  is used to treat reentrant 
supraventricular tachycardia complicating the WPW syndrome, the electrophysiologic effects of 
verapamil on accessory pathway conduction during atrial fibrillation become critical. Patients with 
WPW syndrome have a higher incidence of atrial fibrillation than the general population [10,11]. 
We think that verapamil administered for rhythm and rate control at emergency service induced 
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AF with wide QRS and consequent VF development in our case too. Antz et al. stated that patients 
with WPW syndrome who had undergone CPR for malignant ventricular function had normal left 
ventricular function at echocardiography and no ECG abnormalities and ablation of their 
accessory pathways prevented cardiac arrest recurrences [12]. Catheter ablation is suggested for 
patients resuscitated from VF or for patients at high risk for clinical atrial fibrillation with a rapid 
ventricular response [13].                                                                                           
As a result, Using AV node suppressive medicines in patients with WPW syndrome may cause 
atrial fibrillation followed by development of fatal cardiac arrhythmias. We believe that it is 
important  to acquaint  all the  clinicians, especially the emergency  service  and ambulance 
physicians who are the first to face SVT patients in daily practice, with this issue.                     
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